Executive Equity Diversification: Beyond RSUs and Options
I sat across from a VP of Engineering last spring who had $4.2 million in a single stock. His company's stock. He'd been there nine years, survived two rounds of layoffs, and watched his RSU grants compound into something that looked, on paper, like generational wealth. Then he asked me the question I hear at least once a month: "Should I just... hold it?" Executive equity compensation diversification isn't a nice-to-have for people in his position. It's the single highest-leverage decision they'll make in their financial lives, and most of them are winging it with advice from Reddit and a financial advisor who's never seen a K-1 for incentive stock options.
This post is for the VPs, directors, and C-suite folks sitting on concentrated positions who know, intellectually, that they shouldn't have this much money riding on one ticker. Knowing it and doing something about it are two different problems.
Understanding Executive Equity Packages
Executive equity isn't one thing. It's usually three or four things stapled together, each with its own tax treatment, vesting mechanics, and risk profile.
RSUs (restricted stock units) are the simplest. They vest, they become yours, you owe ordinary income tax on the value at vesting whether you sell or not. No decision required, really, except what to do after they hit your account. Most executives let them pile up because selling feels like betting against the company. That's not investing. That's inertia wearing a suit.
ISOs (incentive stock options) are trickier and more dangerous if you don't understand them. Exercise early, hold too long, and you can get hammered by the alternative minimum tax on phantom gains you haven't actually realized in cash. We've seen executives owe six figures in AMT on stock that then dropped 60% before they could sell it. That's not a hypothetical. That happened to plenty of people in 2022. We've written a full breakdown of exercise strategy in our ISO stock options exercise strategies post, and if you have ISOs on the table, read it before you exercise a single share.
NSOs (non-qualified stock options) are more straightforward tax-wise but still create concentration risk the moment you exercise and hold.
And then there's the stuff people forget to count: ESPP shares, performance stock units tied to company milestones, and sometimes founder-era grants with weird vesting schedules from an acquisition. If you're early in your career and just starting to accumulate equity, our equity compensation guide walks through the basics. This post assumes you're past that stage and sitting on real concentration risk.
The problem with executive packages specifically is that they're often much larger, relative to total net worth, than a typical RSU grant. A director or VP three years post-refresh can easily have 60-80% of their net worth in one company. That's not a compensation package anymore. That's a bet.
Diversification Timeline and Strategies
Here's the uncomfortable truth: there's no perfect time to diversify. There's only a plan and no plan.
The most common mistake we see is executives waiting for a "better price" before selling. This is the same mental trap retail investors fall into, dressed up in a nicer suit. You don't know if the stock is going to $50 or $500. Nobody does, including the CEO. Waiting for a target price isn't a strategy, it's a hope, and hope has a lousy track record as a risk management tool.
What actually works is systematic diversification on a timeline, independent of your view on the stock.
10b5-1 plans are the cleanest tool for this. You set up a pre-arranged selling plan (typically during an open trading window, with a cooling-off period built in per the SEC's amended Rule 10b5-1) and then the sales happen automatically according to the schedule, regardless of what the stock is doing or what material news you might have that week. This removes both the timing temptation and the insider trading risk. If you're an executive with material non-public information most of the time, a 10b5-1 plan isn't optional, it's basically required if you want to sell in a legally clean way.
A dollar-cost-out approach works even without a formal plan. Instead of trying to time one big sale, you sell a fixed percentage of vesting shares every quarter, mechanically. Some executives sell 25% of every RSU vest, immediately, no exceptions. It feels less dramatic than a single "diversification event" and it's psychologically much easier to sustain, because you're never trying to guess the top.
The harder conversation is about how much to diversify, and how fast. Our general framework: any single-stock position above 10-15% of net worth should have an active reduction plan. Above 30%, that plan should be aggressive. We've had executives push back hard on this, especially engineers who did the math on their own company's growth trajectory and feel like they have an information edge. Maybe they do. But an information edge on a company's product roadmap is not the same as an edge on its stock price, and conflating the two is how smart people end up poorer.
Tax-Efficient Exercise and Sale Planning
This is where the real value gets built or destroyed, and it's the part most generic financial advice gets wrong.
Long-term capital gains rates versus short-term matters enormously here. Holding shares (whether from an ISO exercise or post-vest RSU shares) for more than a year from exercise/vest and two years from grant (for ISOs specifically) can shift a sale from ordinary income rates to long-term capital gains rates. That's often the difference between a top marginal rate near 37% federal and a capital gains rate of 15-20%. On a $2 million sale, that's not a rounding error. That's a new car, a kid's college fund, or a meaningful chunk of a diversification plan, depending on how you look at it.
But there's a real tension here: holding longer for tax efficiency means holding more concentration risk. There's no free lunch. The right answer depends on total position size, conviction in the company, other income that year, and honestly temperament. Someone who can't sleep at night watching a single stock swing 8% in a day should not be optimizing purely for tax efficiency. Cash flow and sanity have value too.
AMT and ISO Timing
If you have ISOs, the alternative minimum tax deserves its own paragraph because it trips up smart people constantly. Exercising ISOs and holding creates an AMT preference item equal to the spread between strike price and fair market value, even though you haven't sold anything and haven't received a dollar of cash. The IRS has a decent overview of how this works in Form 6251 instructions, though nobody should be doing this math by hand in the year 2024.
The move that saves people real money: modeling AMT exposure before year-end, not after. Exercising ISOs in January instead of December, spreading exercises across multiple tax years, or coordinating an exercise with a same-year disqualifying disposition to avoid AMT entirely (sacrificing some of the long-term capital gains benefit, but avoiding a phantom tax bill) are all legitimate strategies. Which one is right depends entirely on your specific numbers. This is not a spreadsheet template situation. This is a "get someone who does this professionally to run the actual numbers" situation.
Charitable and Trust Structures
For larger positions, donor-advised funds and charitable remainder trusts can offload appreciated stock without triggering the capital gain, while also creating a current-year deduction. Executives with highly appreciated pre-IPO shares have used this to diversify a meaningful chunk of a position tax-efficiently while also fulfilling philanthropic goals they already had. It's not for everyone. But if you're charitably inclined anyway, it's underused.
Risk Management for Concentrated Positions
Sometimes you can't sell. Lockup periods, blackout windows, insider status, or just a genuine belief that the stock has room to run, whatever the reason, there are ways to manage concentration risk without an outright sale.
Exchange funds let you contribute concentrated stock into a pooled fund alongside other investors with their own concentrated (and different) positions, in exchange for a diversified stake in the fund. You defer the tax event, you get diversification, and after a required holding period (usually seven years) you can exit with a diversified basket instead of one stock. The catch is illiquidity and fees, so this isn't for someone who might need the money in three years.
Protective options strategies, like collars, let you hedge downside risk on a concentrated position (buying a put, financed partly or fully by selling a call) without an outright sale. This can work well for restricted or insider-held stock where selling isn't an option in the near term. It caps your upside too, which is the trade-off, and it's not something to set up without real modeling of the tax and cash implications.
Prepaid variable forward contracts let executives monetize a large chunk of a position's value today (getting cash upfront) while deferring the actual sale and tax event into the future, with some downside protection built in. These are complex instruments with real counterparty and structuring considerations. Worth knowing they exist and that they're used more than people realize at the pre-IPO and post-IPO executive level, not because they're right for most people reading this.
None of these tools are "set and forget." They all require real modeling of your specific tax situation, blackout calendar, and risk tolerance. This is exactly the kind of work our financial planning team does for concentrated-position clients, and it's genuinely different work than managing a diversified portfolio. Different tools, different math, different failure modes.
Estate Planning with Large Equity Holdings
Here's the thing nobody wants to think about while they're busy vesting shares: a large, concentrated equity position is also an estate planning problem, and ignoring it just moves the risk to your kids instead of solving it.
Grantor retained annuity trusts (GRATs) can be a strong fit for volatile, appreciating stock, because they let you transfer future appreciation above a hurdle rate to heirs with minimal gift tax cost, while you retain an annuity stream back. If the stock does well, a lot of upside moves out of your taxable estate. If it doesn't, you're mostly back where you started, tax-wise. That asymmetry is exactly why GRATs get used heavily with concentrated tech stock.
Irrevocable trusts funded with diversified proceeds (post-sale, ideally) are more straightforward and give you more control over how wealth transfers to the next generation, including protecting it from creditors, divorces, and, frankly, from adult children who aren't ready for a lump sum.
The mistake we see most: executives who build detailed diversification plans for their investment portfolio and then completely neglect what happens to that concentrated stock if they get hit by a bus next Tuesday. If you're a VP or executive with a family and a meaningful equity position, your estate plan needs to be built around the actual asset you hold, not a generic template. Our career VP and executive planning guide touches on how this fits into the bigger financial picture at that career stage.
Working with Investment Managers on Equity
Most financial advisors are built to manage diversified portfolios of stocks and bonds. Very few are built to manage the specific, gnarly problem of a $3 million concentrated position sitting next to a family's entire liquid net worth, with vesting schedules, blackout windows, and AMT exposure all interacting at once.
That's a specialized skill. It requires someone who can model a 10b5-1 plan, coordinate exercise timing with your tax return, build the estate structure, and manage the diversified proceeds once they're liquid, all as one connected plan instead of four separate projects run by four separate people who don't talk to each other.
This is a big part of why we built our Passive Income Office™ approach the way we did: active, hands-on management for people with complex, concentrated situations, not a generic model portfolio that ignores the fact that half your net worth moves with one ticker. If you want to see whether your situation fits with how we work, our who we help page is a good place to start, and our team has real experience on both sides of this, tech operators and financial planners, which matters more than people realize when the conversation turns to vesting schedules and AMT.
If you've got a six or seven-figure equity position and you're not sure whether you have a plan or just a hope, that's worth a conversation before your next vest date, not after. Schedule a consultation and let's actually look at your numbers.